Global Antimicrobial Susceptibility Testing Market Size, Share, Growth Analysis, By Test type(Phenotypic testing, genotypic testing), By End user(Hospitals and diagnostic laboratories, research and academic institutes), By Product type(Instruments, reagents and kits) - Industry Forecast 2024-2031

Global Antimicrobial Susceptibility Testing Market size was valued at USD 3.60 Billion in 2022 and is poised to grow from USD 3.79 Billion in 2023 to USD 5.68 Billion by 2031, at a CAGR of 5.20% during the forecast period (2024-2031).

Global Antimicrobial Susceptibility Testing (AST) Market is witnessing substantial growth, driven by the increasing prevalence of antimicrobial resistance and the need for effective treatment strategies. Antimicrobial susceptibility testing plays a crucial role in guiding clinicians to select appropriate antimicrobial therapies for patients, ensuring optimal treatment outcomes, and combating the rise of drug-resistant pathogens. The purpose of the market is to provide accurate and timely information on the susceptibility of microorganisms to various antibiotics. AST helps healthcare professionals make informed decisions regarding antibiotic selection, dosage, and treatment duration, aiding in the effective management of infectious diseases. By identifying the most effective antibiotics, AST enables personalized treatment plans, minimizes the risk of treatment failure, and contributes to antimicrobial stewardship efforts. Several key drivers are fueling the growth of the antimicrobial susceptibility testing market. The escalating burden of antimicrobial resistance, resulting in increased morbidity, mortality, and healthcare costs, drives the demand for AST. Additionally, the rise in infectious disease outbreaks, hospital-acquired infections, and the growing awareness about the need for targeted therapies fuel market expansion. The advent of rapid AST methods, automation, and the integration of molecular diagnostics into AST systems are further driving the market growth.

However, limited accessibility to advanced AST methods, particularly in resource-constrained settings, and the high cost associated with implementing sophisticated testing technologies may hinder the market growth. Moreover, the complexity of interpreting test results, challenges in standardizing testing methods, and the time-consuming nature of traditional AST methods pose challenges to market adoption. Key trends in the antimicrobial susceptibility testing market include the development of rapid and accurate AST systems, the integration of artificial intelligence (AI) and machine learning algorithms for data analysis, and the increasing focus on multiplex testing to detect multiple drug resistance patterns simultaneously. The market also presents significant opportunities for growth and innovation. The increasing demand for point-of-care testing, the adoption of automated AST systems in laboratories, and the growing need for personalized medicine in infectious disease management offer attractive prospects. Furthermore, collaborations between diagnostic companies, research institutions, and healthcare organizations can drive advancements in AST technologies and expand market reach.

US Antimicrobial Susceptibility Testing Market is poised to grow at sustainable CAGR for the next forecast year.